CIK 0001326110 · Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 431979754
- Phone
- (844) 696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,119,848
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,119,848. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-14 | BLASZYK MICHAEL D Director | Grant or award · Stock Option (right to buy) | +167,937 | 167,937 | ||
| 2022-03-23 | Simon Barry J. Director | Grant or award · Stock Option (right to buy) | +10,714 | 10,714 | ||
| 2022-03-23 | Sachs David C. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2022-03-23 | Sachs David C. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2022-03-23 | SOON-SHIONG PATRICK Executive Chairman | Grant or award · Stock Option (right to buy) | +350,000 | 350,000 | ||
| 2022-03-23 | SOON-SHIONG PATRICK Executive Chairman | Grant or award · Stock Option (right to buy) | +350,000 | 350,000 |
Page 12 of 12 · 226 trades